LLY - Eli Lilly and Co News

3 Unstoppable Stocks to Buy Right Now 6:56am / MotleyFool.com - Paid Partner Content	An Important History Lesson for Gene-Editing Investors Dec 02 / MotleyFool.com - Paid Partner Content
Eli Lilly (LLY) Rises Higher Than Market: Key Facts Dec 08 / Zacks.com - Paid Partner Content	Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk? Dec 02 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod Dec 08 / Zacks.com - Paid Partner Content	5 Top Stocks to Buy Before 2024 Dec 02 / MotleyFool.com - Paid Partner Content
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market? Dec 08 / MotleyFool.com - Paid Partner Content	Annovis Bio (ANVS) Stock Surges 38% in a Month: Here's Why Dec 01 / Zacks.com - Paid Partner Content
Zacks Market Edge Highlights: SAIC, ANET, LLY, PFE and SIG Dec 08 / Zacks.com - Paid Partner Content	1 Underrated Reason to Buy Eli Lilly Stock Dec 01 / MotleyFool.com - Paid Partner Content
Will There Be a Recession in 2024? Dec 07 / Zacks.com - Paid Partner Content	Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Dec 01 / Zacks.com - Paid Partner Content
Better Large-Cap Growth Fund: Schwab U.S. Large-Cap Growth or Vanguard Growth Index Fund? Dec 07 / MotleyFool.com - Paid Partner Content	AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion Dec 01 / Zacks.com - Paid Partner Content
Should You Buy Eli Lilly Stock Now or Wait for a Dip? Dec 07 / MotleyFool.com - Paid Partner Content	The Zacks Analyst Blog Highlights AbbVie, J&J, Eli Lilly, Pfizer Nov 30 / Zacks.com - Paid Partner Content
Which Stock Is More Likely to Help You Retire as a Millionaire: AbbVie or Eli Lilly? Dec 07 / MotleyFool.com - Paid Partner Content	Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy? Nov 30 / MotleyFool.com - Paid Partner Content
Amgen: Relative Valuation Remains Unattractive Dec 06 / GuruFocus News - Paid Partner Content	Alexandria (ARE), Eli Lilly to Expand Gateway Labs to San Diego Nov 29 / Zacks.com - Paid Partner Content
Is it a Good Idea to Invest in AC Immune (ACIU) Stock Now? Dec 05 / Zacks.com - Paid Partner Content	4 Large Drug Stocks to Watch as IBD Market Gains Traction Nov 29 / Zacks.com - Paid Partner Content
Lilly (LLY) Gets Second FDA Nod for Lymphoma Drug Jaypirca Dec 04 / Zacks.com - Paid Partner Content	Is Invesco Large Cap Growth ETF (PWB) a Strong ETF Right Now? Nov 29 / Zacks.com - Paid Partner Content
Roche (RHHBY) to Acquire Obesity Drug Maker Carmot for $2.7B Dec 04 / Zacks.com - Paid Partner Content	Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock? Nov 29 / MotleyFool.com - Paid Partner Content
Altimmune (ALT) Rises 83% on Successful Phase II Obesity Study Dec 04 / Zacks.com - Paid Partner Content	3 Large Drug Stocks That Have Outperformed Industry YTD Nov 28 / Zacks.com - Paid Partner Content
1 Monster Dividend Stock Growth Investors Should Load Up On Right Now Dec 04 / MotleyFool.com - Paid Partner Content	Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? Nov 28 / Zacks.com - Paid Partner Content
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead. Dec 04 / MotleyFool.com - Paid Partner Content	3 Top Stocks That'll Make Smart Investors Rich Nov 27 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Stock Down 5% as Obesity Drug Fails in Phase II Dec 04 / Zacks.com - Paid Partner Content	The Zacks Analyst Blog Highlights Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce Nov 27 / Zacks.com - Paid Partner Content
3 No-Brainer Growth Stocks to Buy in December Dec 03 / MotleyFool.com - Paid Partner Content